ACS Meeting and Speaker!
Learn about the path from undergraduate to post-doc!
Monday, February 15, 2016 · 12 - 12:50 PM
In-Person
·
Meyerhoff Chemistry : 030
At our next meeting, we will be hosting Dr. Sarah Zimmerman, who will be discussing her journey from being an undergraduate to her current post-doctoral work at Johns Hopkins as well as her current research in the Johns Hopkins Drug Discovery Program. This should be a really great and informative talk so please come out and join us! See her entire talk description below for more information.
"Dr. Zimmermann will briefly discuss her path from undergraduate to her current post-doctoral position, and the current research she is performing during her post-doc at Johns Hopkins. Dr. Zimmermann completed her undergraduate degree at Lynchburg College, and during that time was able to gain experience by completing undergraduate research, interning at a local company, as well as participating in a NIH funded REU. After completing her bachelor’s degree Dr. Zimmermann attended UMBC for her PhD studies under the tutelage of Dr. Katherine Seley-Radtke. Her research in Dr. Seley’s lab focused on the synthesis of modified nucleosides with a flexible nucleobase, “Fleximers,” to study their inhibitory properties towards adenosine recognizing enzymes such as S-adenosylhomocysteine hydrolase and adenosine deaminase. Following her PhD work Dr. Zimmermann went on to post-doc with Dr. Takashi Tsukamoto at the Johns Hopkins Drug Discovery (JHDD) Program. The JHDD is part of a multidisciplinary translational research lab that performs medicinal chemistry, drug screening and assay development, drug metabolism and pharmacokinetics as well as animal pharmacology. Since joining JHDD Dr. Zimmermann has been awarded an NIH postdoctoral fellowship to study the inhibition of glutaminase as a target for treating glutamine dependent cancers, which is the project that will be further discussed during her presentation on 02/15/16."
"Dr. Zimmermann will briefly discuss her path from undergraduate to her current post-doctoral position, and the current research she is performing during her post-doc at Johns Hopkins. Dr. Zimmermann completed her undergraduate degree at Lynchburg College, and during that time was able to gain experience by completing undergraduate research, interning at a local company, as well as participating in a NIH funded REU. After completing her bachelor’s degree Dr. Zimmermann attended UMBC for her PhD studies under the tutelage of Dr. Katherine Seley-Radtke. Her research in Dr. Seley’s lab focused on the synthesis of modified nucleosides with a flexible nucleobase, “Fleximers,” to study their inhibitory properties towards adenosine recognizing enzymes such as S-adenosylhomocysteine hydrolase and adenosine deaminase. Following her PhD work Dr. Zimmermann went on to post-doc with Dr. Takashi Tsukamoto at the Johns Hopkins Drug Discovery (JHDD) Program. The JHDD is part of a multidisciplinary translational research lab that performs medicinal chemistry, drug screening and assay development, drug metabolism and pharmacokinetics as well as animal pharmacology. Since joining JHDD Dr. Zimmermann has been awarded an NIH postdoctoral fellowship to study the inhibition of glutaminase as a target for treating glutamine dependent cancers, which is the project that will be further discussed during her presentation on 02/15/16."